These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26663765)

  • 1. Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.
    Cioni M; Leboeuf C; Comoli P; Ginevri F; Hirsch HH
    Am J Transplant; 2016 Apr; 16(4):1193-206. PubMed ID: 26663765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in BK Polyomavirus Immunodominant Large Tumor Antigen-Specific 9mer CD8 T-Cell Epitopes Predict Altered HLA-Presentation and Immune Failure.
    Leuzinger K; Kaur A; Wilhelm M; Hirsch HH
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33371492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
    Leboeuf C; Wilk S; Achermann R; Binet I; Golshayan D; Hadaya K; Hirzel C; Hoffmann M; Huynh-Do U; Koller MT; Manuel O; Mueller NJ; Mueller TF; Schaub S; van Delden C; Weissbach FH; Hirsch HH;
    Am J Transplant; 2017 Oct; 17(10):2591-2600. PubMed ID: 28326672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Zaaijer HL; Kroes AC; van Zwet EW; Rotmans JI; Feltkamp MC
    J Clin Virol; 2017 May; 90():46-51. PubMed ID: 28355579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
    Kaur A; Wilhelm M; Wilk S; Hirsch HH
    Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
    Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
    Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
    Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
    Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.
    Chakera A; Bennett S; Lawrence S; Morteau O; Mason PD; O'Callaghan CA; Cornall RJ
    Clin Exp Immunol; 2011 Sep; 165(3):401-9. PubMed ID: 21671906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyomavirus BK-Specific CD4+ T Cells Response to VP1 Stimulation in Kidney Transplant Recipients.
    Noshadi N; Yaghoubi R; Afshari A; Forouzanfar M; Soleimanian S
    Iran J Allergy Asthma Immunol; 2024 May; 23(3):272-287. PubMed ID: 39422387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
    van Aalderen MC; Remmerswaal EB; Heutinck KM; Ten Brinke A; Feltkamp MC; van der Weerd NC; van der Pant KA; Bemelman FJ; van Lier RA; Ten Berge IJ
    PLoS Pathog; 2016 Oct; 12(10):e1005903. PubMed ID: 27723787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK Polyomavirus-Specific CD8 T-Cell Expansion In Vitro Using 27mer Peptide Antigens for Developing Adoptive T-Cell Transfer and Vaccination.
    Wilhelm M; Kaur A; Wernli M; Hirsch HH
    J Infect Dis; 2021 Apr; 223(8):1410-1422. PubMed ID: 32857163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.
    Kotton CN; Kamar N; Wojciechowski D; Eder M; Hopfer H; Randhawa P; Sester M; Comoli P; Tedesco Silva H; Knoll G; Brennan DC; Trofe-Clark J; Pape L; Axelrod D; Kiberd B; Wong G; Hirsch HH;
    Transplantation; 2024 Sep; 108(9):1834-1866. PubMed ID: 38605438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.